1800 202 8726
Insurance & Molecular Testing

Is Molecular Testing — Covered by Insurance?

Most private insurers in India refuse molecular cancer tests, calling them investigational. Whether you are reimbursed depends on which scheme or policy you hold — and on the paperwork you gather before the test, not after.

Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist, MBBS (AIIMS) · MS Surgery (AIIMS) · DNB Surg Onc · MRCS (Edinburgh) · Last reviewed September 2026

  • Usually refused — Most private insurers classify molecular tests as investigational and decline the claim.
  • Government schemes vary — CGHS and PM-JAY cover some molecular tests when prescribed for a treatment decision.
  • Before beats after — Prior authorisation, obtained before the test, is the strongest protection against a refusal.
  • Appeals can work — An oncologist's letter citing clinical guidelines has overturned refusals.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Most private insurers in India classify molecular testing as investigational and refuse it. Government schemes — CGHS and PM-JAY — cover some tests when ordered for a treatment decision. The single most important step is to get prior authorisation from your insurer and a clinical necessity letter from your oncologist before the test is done.

Why do insurers say molecular testing is not covered?

Most private insurance policies in India were written before molecular testing became standard care for several cancers. The word 'investigational' in your policy was meant to exclude unproven experiments — not tests that NCCN, ASCO and ESMO now recommend routinely.

The label has not caught up with the evidence. Your oncologist's letter explaining why this specific test is needed for your treatment decision — not molecular testing in general — is what moves a claim from automatic refusal to actual review.

What do these terms on your policy or claim form actually mean?

Molecular testing / biomarker testing
Laboratory analysis of your tumour tissue or blood to find the specific genetic changes driving your cancer. The result guides which treatments are likely to work for you.
NGS (Next-Generation Sequencing)
A single test that reads many genes or the entire tumour genome at once. Often the test that triggers an 'investigational' refusal, though it is now standard in many oncology guidelines.
Investigational or experimental
A policy term, not a medical one. It means not yet established as standard care. It can be challenged when your oncologist cites a named body — NCCN, ESMO, ASCO or ICMR — that recommends the test for your situation.
Prior authorisation (PA)
Approval from your insurer obtained before the test is done. Without it, even tests that would qualify are commonly declined on a procedural technicality.
CGHS
Central Government Health Scheme. Covers central government employees, pensioners and their dependants. Reimburses some diagnostic tests at fixed rates when prescribed by an empanelled doctor.
PM-JAY / Ayushman Bharat
Government scheme for eligible low-income families. Covers cancer-related diagnostics at empanelled hospitals. Which molecular tests qualify varies by state and is updated periodically.

What documents do I need to make or appeal a claim?

  • Oncologist's letter: states the test name, why it is needed for your specific treatment decision, and which guideline recommends it
  • Prior authorisation approval from your insurer, or the date you applied if still pending
  • Original prescription or treatment plan from your oncologist
  • Complete laboratory report, including NABL or CAP accreditation details
  • Itemised invoice showing the test name and cost — not a summary bill
  • Insurer's written refusal letter, if they declined — needed to begin a formal appeal

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Which schemes cover molecular tests — and what do they require?

SchemeWho qualifiesCoverage for molecular testsKey requirement
CGHSCentral govt employees and pensionersSome biomarker tests at fixed rates when prescribed for treatmentEmpanelled doctor referral; prior approval for high-cost tests
PM-JAY / Ayushman BharatEligible low-income families with a PM-JAY cardSelect cancer diagnostics; specific molecular tests vary by stateEmpanelled hospital; test must appear in the current Health Benefit Package
ESIFormal-sector employees below the wage thresholdFollows CGHS rates; molecular test coverage is limitedESI-empanelled facility; medical officer referral
Private health insurancePolicy holdersUsually refused as investigational; some oncology add-on policies include NGSPrior authorisation before the test; oncologist's clinical necessity letter

What can I do if my insurer refuses?

How do I appeal a refusal?

Ask for the refusal in writing first. Your appeal letter should explain why the test was needed for your specific treatment decision — not why molecular testing is useful in general. Attach your oncologist's letter citing the relevant guideline by name (NCCN, ESMO, ASCO or ICMR), the laboratory report, and the itemised invoice. If the insurer's grievance process does not resolve it, you can escalate to the Insurance Ombudsman (Bima Lokpal), which hears policy disputes without a fee and without requiring a lawyer.

Can I get reimbursed after paying out of pocket?

Yes, if your policy has a reimbursement track and the test would otherwise have qualified. You will need the oncologist's letter, original itemised invoice, prescription and full test report. The risk of skipping prior authorisation is that the insurer can decline on procedural grounds even if the test qualifies. If the test was urgent and you could not wait, include a brief written explanation of the clinical urgency — some insurers accept this, though prior authorisation beforehand is always the safer route.

What should my oncologist's letter actually say?

The most useful letter is specific, not general. It should state your diagnosis, the exact test name, what clinical decision the result will inform — for example, whether a particular class of treatment is suitable — and which guideline body recommends this test for your cancer type and stage. Generic letters about the value of precision medicine are weaker than a targeted statement linking your case to a named clinical standard. Where accurate, the phrase 'standard of care' and a citation to the guideline document by name carry real weight in an appeal.

What if I am on PM-JAY and the hospital says the test is not covered?

PM-JAY benefit packages are updated periodically, and what is covered varies by state. Ask the hospital's PM-JAY coordinator to check the current Health Benefit Package for your specific cancer type — the list changes and staff are not always up to date. If the test is genuinely not in the package for your state, ask whether a different empanelled hospital offers it, or whether your oncologist can make a case to the State Health Agency. The State Health Agency is the authority on what is available in your state.

Did you know?

The ICMR National Cancer Grid recommends biomarker testing before starting systemic therapy for several common cancers — yet many insurance policies in India still classify these same tests as investigational.

When your oncologist cites that guidance by name, the word 'investigational' on a refusal letter becomes a much weaker argument.

Source: ICMR National Cancer Grid — Guidelines for the Treatment of Cancer

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

HUB — How Accurate Is a Biopsy? Repeats, Errors and Second Opinions

HUB — IHC and Molecular Markers on a Biopsy

HUB — Labs, Slides and Second Opinions on a Biopsy

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is molecular testing covered by health insurance in India?

It depends on your scheme. Most private health insurance policies refuse molecular tests as investigational. Government schemes — CGHS and PM-JAY — cover some tests at empanelled facilities when prescribed for a treatment decision. The most important step is to apply for prior authorisation before the test, and to have your oncologist write a letter tying the specific test to a specific clinical decision in your case.

What does 'investigational' mean on an insurance refusal?

'Investigational' is a policy term, not a medical one. Insurers use it to mean not yet established as standard care. It can be challenged if your oncologist shows that NCCN, ESMO, ASCO or ICMR recommends the test for your specific cancer type and stage. A letter citing the guideline by name, with your diagnosis and the test linked to a treatment decision, is the starting point for an appeal.

Does Ayushman Bharat cover molecular testing?

PM-JAY covers a package of cancer-related services including some diagnostics, but which molecular tests are included varies by state and is updated regularly. Ask the PM-JAY coordinator at your empanelled hospital to check the current Health Benefit Package for your cancer type before assuming the test is not covered. The State Health Agency can confirm what is available in your state.

How long does an insurance appeal take?

Most insurers have a formal grievance process and must respond within a set period — check your policy for the stated timeline. If the insurer does not resolve the dispute satisfactorily, you can escalate to the Insurance Ombudsman (Bima Lokpal), which handles policyholder complaints without a fee or legal representation. Keep copies of every letter you send and receive, with dates, because the timeline matters in any escalation.

What if I paid for the test and the insurer refuses to reimburse me?

You can still appeal using the oncologist's letter, original itemised invoice and test report. Without prior authorisation, the insurer may decline on procedural grounds regardless of the test's clinical justification. If the test was urgent and you could not wait, include a written explanation of that urgency. If the appeal fails, escalate to the Insurance Ombudsman (Bima Lokpal).

Is there financial support if insurance does not cover the test?

Ask the hospital's oncology social worker or patient services team what is available locally — some hospitals and cancer trusts offer partial support for diagnostic costs. Out-of-pocket medical expenses for cancer may also qualify for a tax deduction under Section 80DDB of the Income Tax Act; the limits are revised in the annual Budget, so check the current figure with a tax adviser and keep all original bills and reports as documentation.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation